Firetrail Investments PTY Ltd. cut its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) by 35.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 139,470 shares of the company’s stock after selling 77,160 shares during the period. Ryan Specialty accounts for approximately 2.7% of Firetrail Investments PTY Ltd.’s portfolio, making the stock its 22nd biggest holding. Firetrail Investments PTY Ltd. owned 0.05% of Ryan Specialty worth $9,250,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. Hollencrest Capital Management bought a new position in Ryan Specialty in the 3rd quarter worth approximately $25,000. Assetmark Inc. bought a new position in Ryan Specialty during the third quarter worth $34,000. GAMMA Investing LLC raised its stake in Ryan Specialty by 96.4% during the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after purchasing an additional 297 shares during the last quarter. Crewe Advisors LLC bought a new stake in Ryan Specialty in the 2nd quarter valued at $39,000. Finally, Rothschild Investment LLC acquired a new stake in Ryan Specialty in the 2nd quarter worth $87,000. Institutional investors and hedge funds own 84.82% of the company’s stock.
Ryan Specialty Trading Up 0.1 %
Shares of Ryan Specialty stock opened at $71.72 on Thursday. The stock has a market capitalization of $18.78 billion, a P/E ratio of 93.14, a price-to-earnings-growth ratio of 1.63 and a beta of 0.62. Ryan Specialty Holdings, Inc. has a 12-month low of $41.49 and a 12-month high of $73.10. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The company has a 50-day simple moving average of $68.01 and a 200 day simple moving average of $61.60.
Ryan Specialty Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th will be issued a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.61%. Ryan Specialty’s dividend payout ratio is 57.14%.
Insider Buying and Selling
In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $64.69, for a total value of $2,264,150.00. Following the completion of the sale, the director now owns 19,251 shares in the company, valued at approximately $1,245,347.19. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,790 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the transaction, the executive vice president now directly owns 12,386 shares of the company’s stock, valued at approximately $884,236.54. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $64.69, for a total value of $2,264,150.00. Following the completion of the transaction, the director now owns 19,251 shares in the company, valued at $1,245,347.19. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 94,193 shares of company stock worth $6,208,493 in the last 90 days. Corporate insiders own 11.10% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms recently weighed in on RYAN. Barclays started coverage on shares of Ryan Specialty in a research note on Wednesday, September 4th. They issued an “overweight” rating and a $76.00 target price for the company. Bank of America lifted their price objective on Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a report on Thursday, October 10th. UBS Group upped their target price on Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a research note on Tuesday, August 13th. JPMorgan Chase & Co. lifted their price target on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a research note on Friday, August 2nd. Finally, Wells Fargo & Company increased their price objective on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. One analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $70.33.
View Our Latest Stock Analysis on RYAN
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Recommended Stories
- Five stocks we like better than Ryan Specialty
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Unusual Trading Volume in Gerdau: A Signal for Buyers?
- Do ETFs Pay Dividends? What You Need to Know
- 3 Stocks Gaining Traction in Their Turnaround Stories
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.